Literature DB >> 27891339

Bacteriological Profile of Isolates From Urine Samples in Patients of Benign Prostatic Hyperplasia and or Prostatitis Showing Lower Urinary Tract Symptoms.

Prem Prakash Mishra1, Ved Prakash2, Kashmir Singh3, H Mog4, Sumit Agarwal4.   

Abstract

INTRODUCTION: The incidence of Benign Prostatic Hyperplasia (BPH) or Prostatitis is increasing considerably worldwide. The Lower Urinary Tract Symptoms (LUTS) due to bacterial aetiology are one of the common factors for the complications among the patients. AIM: To determine the bacterial agents and their antibiotic sensitivity pattern from the urine samples of patients of BPH or Prostatitis showing symptoms of LUTS.
MATERIALS AND METHODS: The cross-sectional study was carried out in the Department of Microbiology of Rohilkhand Medical College and Hospital of Northern India from June 2014 to May 2015. A total of 105 urine specimens from patients of BPH and/ or Prostatitis were cultured by a semi-quantitative method. The isolated bacteria were identified by colony morphology, Gram's staining, motility and biochemical tests. Antibiotic sensitivity was done according to the CLSI 2007 guidelines by disc diffusion method. Data was analysed by SPSS and Microsoft office 2007. Proportions and percentages were used as statistical measures.
RESULTS: The urine cultures from patients with BPH and or chronic Prostatitis, showed n=66/105 (62.85%) culture positivity. Out of 66 isolates the frequency was in following order Escherichia coli 21/66 (31.81%), Klebsiella spp 19/66 (28.78%), Staphylococcus aureus 11/66 (16.66%), Pseudomonas aeruginosa (10.60%), Proteus spp, Enterococcus spp, Acinetobacter spp and Citrobacter spp. The most susceptible 1st, 2nd and 3rd line antibiotics for Gram negative isolates were ampicillin, amikacin and tigecycline respectively. Amongst the Gram positive isolates, the susceptible 1st, 2nd and 3rd line antibiotics were cefoxitin, vancomycin, teicoplanin and linezolid. Multidrug resistance was seen in Escherichia coli (n=6), Klebsiella spp (n=7), Pseudomonas aeruginosa (n=4) and Staphylococcus aureus (n=3).
CONCLUSION: Based on the above findings we can say that accurate aetiology of the LUTS among the patients of BPH and/or Prostatitis is warranted to initiate the therapeutic management. Based on our study we state that the prime pathogens are E.coli, Klebsiella among Gram negative isolates and S. aureus among Gram positive. The most sensitive drugs are aminoglycosides, tetracyclines and carbepenems for Gram neagtive isolates and oxazolidinones and glycopeptides among Gram positive isolates.

Entities:  

Keywords:  Bacteria; Prostate; Urological disorders

Year:  2016        PMID: 27891339      PMCID: PMC5121677          DOI: 10.7860/JCDR/2016/21973.8734

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

1.  Role of inflammation in benign prostatic hyperplasia.

Authors:  Bilal Chughtai; Richard Lee; Alexis Te; Steven Kaplan
Journal:  Rev Urol       Date:  2011

Review 2.  Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management.

Authors:  Jack Barkin
Journal:  Can J Urol       Date:  2011-04       Impact factor: 1.344

Review 3.  Benign prostatic hyperplasia: what about a campaign for prevention?

Authors:  F Di Silverio; V Gentile; A L Pastore; G Voria; G Mariotti; A Sciarra
Journal:  Urol Int       Date:  2004       Impact factor: 2.089

4.  Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.

Authors:  Rachel S Edlin; Chris F Heyns; Stephan P J Van Vuuren; Amir D Zarrabi
Journal:  S Afr J Surg       Date:  2012-11-12       Impact factor: 0.375

5.  Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years.

Authors:  J Kellogg Parsons; Jaclyn Bergstrom; Jonathan Silberstein; Elizabeth Barrett-Connor
Journal:  Urology       Date:  2008-06-12       Impact factor: 2.649

6.  Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.

Authors:  J Kellogg Parsons
Journal:  Curr Bladder Dysfunct Rep       Date:  2010-09-07

7.  Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk.

Authors:  S-C Hung; S-W Lai; P-Y Tsai; P-C Chen; H-C Wu; W-H Lin; F-C Sung
Journal:  Br J Cancer       Date:  2013-04-23       Impact factor: 7.640

8.  Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction.

Authors:  Nishant D Patel; J Kellogg Parsons
Journal:  Indian J Urol       Date:  2014-04

9.  Hospital and Community Isolates of Uropathogens and their Antibiotic Sensitivity Pattern from a Tertiary Care Hospital in North West India.

Authors:  A Singhal; R Sharma; M Jain; L Vyas
Journal:  Ann Med Health Sci Res       Date:  2014-01

10.  Management of the complications of BPH/BOO.

Authors:  Mark J Speakman; Xi Cheng
Journal:  Indian J Urol       Date:  2014-04
View more
  2 in total

1.  Uropathogenic Escherichia coli-induced fibrosis, leading to lower urinary tract symptoms, is associated with type 2 cytokine signaling.

Authors:  Ashlee Bell-Cohn; Daniel J Mazur; Christel Hall; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-09

2.  Phenolic Content and Antimicrobial and Anti-Inflammatory Effects of Solidago virga-aurea, Phyllanthus niruri, Epilobium angustifolium, Peumus boldus, and Ononis spinosa Extracts.

Authors:  Claudio Ferrante; Annalisa Chiavaroli; Paola Angelini; Roberto Venanzoni; Giancarlo Angeles Flores; Luigi Brunetti; Massimiliano Petrucci; Matteo Politi; Luigi Menghini; Sheila Leone; Lucia Recinella; Gokhan Zengin; Gunes Ak; Massimo Di Mascio; Francesco Bacchin; Giustino Orlando
Journal:  Antibiotics (Basel)       Date:  2020-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.